Arthrex Seeks High Court Review In $95M Loss On Surgical Method Patent
WASHINGTON, D.C. — Asking for a review of a $95 million judgment, Arthrex Inc. argues in an Oct. 30 petition for a writ of certiorari to the U.S. Supreme Court that...To view the full article, register now.
Already a subscriber? Click here to view full article